Suppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1

Human Molecular Genetics

Volumn 11, Issue 21, 2002, Pages 2657-2672

  Kazemi Esfarjani, Parsa ^a   Benzer, Seymour ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; POLYGLUTAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOTOXICITY; DEGENERATIVE DISEASE; DROSOPHILA; EYE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE REPRESSION; GENETIC DISORDER; GENETIC SCREENING; HUMAN; HUNTINGTON CHOREA; MOLECULAR GENETICS; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN AGGREGATION; RETINA; SEQUENCE HOMOLOGY; SUPPRESSOR GENE;

ANIMALIA; DROSOPHILA;

EID: 0036796287     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.21.2657     Document Type: Article

References (75)

1. Kaytor, M.D. and Warren, S.T. (1999) Aberrant protein deposition and neurological disease. J Biol. Chem., 274, 37507-37510.
2. Trottier, Y., Lutz, Y., Stevanin, G., Imbert, G., Devys, D., Cancel, G., Saudou, F., Weber, C., David, G., Tora, L. et al. (1995) Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature, 378, 403-406.
3. Davies, SW, Turmaine, M., Cozens, B.A., DiFiglia, M., Sharp, A.H., Ross, C.A., Scherzinger, E., Wanker, E.E., Mangiarini, L. and Bates, G.P. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell, 90, 537-548.
4. DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.R, Vonsattel, J.P. and Aronin, N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science, 277, 1990-1993.
5. Cummings, C.J., Mancini, M.A., Antalffy, B., DeFranco, D.B., Orr, H.T. and Zoghbi, H.Y. (1998) Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet., 19, 148-154.
6. Wyttenbach, A., Carmichael, J., Swartz, J., Furlong, R.A., Narain, Y., Rankin, J. and Rubinsztein, D.C. (2000) Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease. Proc. Natl Acad. Sci. USA, 97, 2898-2903.
7. Kobayashi, Y., Kume, A., Li, M., Doyu, M., Hata, M., Ohtsuka, K. and Sobue, G. (2000) Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J Biol. Chem., 275, 8772-8778.
8. Bence, N.F., Sampat, R.M. and Kopito, R.R. (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science, 292, 1552-1555.
9. Chai, Y., Koppenhafer, S.L., Shoesmith, S.J., Perez, M.K. and Paulson, H.L. (1999) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet., 8, 673-682.
10. McCampbell, A., Taylor, J.P., Taye, A.A., Robitschek, J., Li, M., Walcott, J., Merry, D., Chai, Y., Paulson, H., Sobue, G. et al. (2000) CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet., 9, 2197-2202.
11. Nucifora, F.C., Sasaki, M., Peters, M.F., Huang, H., Cooper, J.K., Yamada, M., Takahashi, H., Tsuji, S., Troncoso, J., Dawson, V.L. et al. (2001) Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science, 291, 2423-2428.
12. Shimohata, T., Nakajima, T., Yamada, M., Uchida, C., Onodera, O., Naruse, S., Kimura, T., Koide, R., Nozaki, K., Sano, Y. et al. (2000) Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat. Genet., 26, 29-36.
13. Steffan, J.S., Kazantsev, A., Spasic-Boskovic, O., Greenwald, M., Zhu, Y.Z., Gohler, H., Wanker, E.E., Bates, G.R, Housman, D.E. and Thompson, L.M. (2000) The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl Acad. Sci. USA, 97, 6763-6768.
14. Holbert, S., Denghien, I., Kiechle, T., Rosenblatt, A., Wellington, C., Hayden, M.R., Margolis, R.L., Ross, C.A., Dausset, J., Ferrante, R.J. et al. (2001) The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc. Nad Acad Sci. USA, 98, 1811-1816.
15. Boutell, J.M., Thomas, R, Neal, J.W, Weston, VJ., Duce, J., Harper, P.S. and Jones, A.L. (1999) Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. Hum. Mol. Genet., 8, 1647-1655.
16. Kazantsev, A., Preisinger, E., Dranovsky, A., Goldgaber, D. and Housman, D. (1999) Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc. Natl Acad Sci. USA, 96, 11 404-11 409.
17. Li, S.H., Cheng, A.L., Li, H. and Li, X.J. (1999) Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin. J. Neurosci., 19, 5159-5172.
18. Portera-Cailliau, C., Hedreen, J.C., Price, D.L. and Koliatsos, V.E. (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J Neurosci., 15, 3775-3787.
19. Wellington, C.L., Ellerby, L.M., Hackam, A.S., Margolis, R.L., Trifiro, M.A., Singaraja, R., McCutcheon, K., Salvesen, G.S., Propp, S.S., Bromm, M. et al. (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol. Chem., 273, 9158-9167.
20. Ona, V.O., Li, M.W, Vonsattel, J.P.G., Andrews, L.J., Khan, S.Q., Chung, WM., Frey, A.S., Menon, A.S., Li, X.J., Stieg, P.E. et al. (1999) Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature, 399, 263-267.
21. Kalchman, M.A., Koide, H.B., McCutcheon, K., Graham, R.K., Nichol, K., Nishiyama, K., Kazemi-Esfarjani, P., Lynn, F.C., Wellington, C., Metzler, M. et al. (1997) HIP1, a human homolog of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nat. Genet., 16, 44-53.
22. Sittler, A., Walter, S., Wedemeyer, N., Hasenbank, R., Scherzinger, E., Eickhoff, H., Bates, G.P., Lehrach, H. and Wanker, E.E. (1998) SH3GL3 associates with the huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. Mol. Cell, 2, 427-436.
23. Waragai, M., Lammers, C.H., Takeuchi, S., Imafuku, I., Udagawa, Y., Kanazawa, I., Kawabata, M., Mouradian, M.M. and Okazawa, H. (1999) PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Bm-2 and affects cell survival. Hum. Mol. Genet., 8, 977-987.
24. Cha, J.H., Kosinski, C.M., Kerner, J.A., Alsdorf, S.A., Mangiarini, L., Davies, S.W., Penney, J.B., Bates, G.P. and Young, A.B. (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc. Natl Acad. Sci. USA, 95, 6480-6485.
25. Chen, N.S., Luo, T., Wellington, C., Metzler, M., McCutcheon, K., Hayden, M.R. and Raymond, L.A. (1999) Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin. J Neurochem., 72, 1890-1898.
26. Reynolds, G.P., Dalton, C.F., Tillery, C.L., Mangiarini, L., Davies, S.W. and Bates, G.R (1999) Brain neurotransmitter deficits in mice transgenic for the Huntington's disease mutation. J. Neurochem., 72, 1773-1776.
27. Warrick, J.M., Paulson, H.L., Gray-Board, G.L., Bui, Q.T., Fischbeck, K.H., Pittman, R.N. and Bonini, N.M. (1998) Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell, 93, 939-949.
28. Jackson, G.R., Salecker, I., Dong, X., Yao, X., Arnheim, N., Faber, P.W., MacDonald, M.E. and Zipursky, S.L. (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron, 21, 633-642.
29. Marsh, J.L., Walker, H., Theisen, H., Zhu, Y.Z., Fielder, T., Purcell, J. and Thompson, L.M. (2000) Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum. Mol. Genet., 9, 13-25.
30. Kazemi-Esfarjani, P. and Benzer, S. (2000) Genetic suppression of polyglutamine toxicity in Drosophila. Science, 287, 1837-1840.
31. Fernandez-Funez, P., Nino-Rosales, M.L., de Gouyon, B., She, W.C., Luchak, J.M., Martinez, P., Turiegano, E., Benito, J., Capovilla, M., Skinner, P.J. et al. (2000) Identification of genes that modify ataxin-1-induced neurodegeneration. Nature, 408, 101-106.
32. Chan, HX, Warrick, J.M., Gray-Board, G.L., Paulson, H.L. and Bonini, N.M. (2000) Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum. Mol. Genet., 9, 2811-2820.
33. Warrick, J.M., Chan, H.Y.E., Gray-Board, G.L., Chai, Y.H., Paulson, H.L. and Bonini, N.M. (1999) Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet., 23, 425-428.
34. Auluck, P.K., Chan, H.Y., Trojanowski, J.Q., Lee, V.M. and Bonini, N.M. (2002) Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease. Science, 295, 865-868.
35. Groves, M.R. and Barford, D. (1999) Topological characteristics of helical repeat proteins. Curr. Opin. Struct. Biol., 9, 383-389.
36. Murthy, A.E., Bernards, A., Church, D., Wasmuth, J. and Gusella, J.F. (1996) Identification and characterization of two novel tetratricopeptide repeat-containing genes. DNA. Cell Biol., 15, 727-735.
37. Xiang, S.L., Kumano, T., Iwasaki, S.I., Sun, X., Yoshioka, K. and Yamamoto, K.C. (2001) The J domain of Tpr2 regulates its interaction with the proapoptotic and cell-cycle checkpoint protein, Rad9. Biochem. Biophys. Res. Commun., 287, 932-940.
38. Steffan, J.S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B.L., Kazantsev, A., Schmidt, E., Zhu, Y.Z., Greenwald, M. et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature, 413, 739-743.
39. Brand, A.H. and Perrimon, N. (1993) Targeted gene gxpression as a means of altering cell fates and generating dominant phenotypes. Development, 118, 401-415.
40. Hay, B.A., Wolff, T. and Rubin, G.M. (1994) Expression of baculovirus P35 prevents cell-death in Drosophila. Development, 120, 2121-2129.
41. Ellis, M.C., Oneill, E.M. and Rubin, G.M. (1993) Expression of Drosophila GLASS protein and evidence for negative regulation of its activity in nonneuronal cells by another DNA-binding protein. Development, 119, 855-865.
42. Freeman, M. (1996) Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye. Cell, 87, 651-660.
43. Torroja, L., Chu, H., Kotovsky, I. and White, K. (1999) Neuronal overexpression of APPL, the Drosophila homolog of the amyloid precursor protein (APP), disrupts axonal transport. Curr. Biol., 9, 489-492.
44. Martindale, D., Hackam, A., Wieczorek, A., Ellerby, L., Wellington, C., McCutcheon, K., Singaraja, R., Kazemi, E.P., Devon, R., Kim, S.U. et al. (1998) Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat. Genet., 18, 150-154.
45. Lunkes, A. and Mandel, J.L. (1998) A cellular model that recapitulates major pathogenic steps of Huntington's disease. Hum. Mol. Genet., 7, 1355-1361.
46. Hackam, A.S., Singaraja, R., Wellington, C.L., Metzler, M., McCutcheon, K., Zhang, T., Kalchman, M. and Hayden, M.R. (1998) The influence of huntingtin protein size on nuclear localization and cellular toxicity. J Cell Biol., 141, 1097-1105.
47. Reddy, G.V. and Rodrigues, V. (1999) Sibling cell fate in the Drosophila adult external sense organ lineage is specified by Prospero function, which is regulated by Numb and Notch. Development, 126, 2083-2092.
48. Doe, C.Q., Chu-LaGraff, Q., Wright, D.M. and Scott, M.P. (1991) The prospero gene specifies cell fates in the Drosophila central nervous system. Cell, 65, 451-464.
49. Rørth, R (1996) A modular misexpression screen in Drosophila detecting tissue-specific phenotypes. Proc. Natl Acad Sci. USA, 93, 12418-12422.
50. Pirrotta, R.V (1986) Cloning Drosophila genes. In Roberts, D.B. (ed.), Drosophila: A Practical Approach. IRL Press, Oxford, pp. 83-110.
51. Yoneda-Kato, N., Look, A.T., Kirstein, M.N., Valentine, M.B., Raimondi, S.C., Cohen, K.J., Carroll, A.J. and Morris, S.W. (1996) The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene, 12, 265-275.
52. Ohno, K., Takahashi, Y., Hirose, R, Inoue, YH., Taguchi, O., Nishida, Y., Matsukage, A. and Yamaguchi, M. (2000) Characterization of a Drosophila homolog of the human myelodysplasia/myeloid leukemia factor (MLF). Gene, 260, 133-143.
53. Adams, M.D., Celniker, S.E., Holt, R.A., Evans, C.A., Gocayne, J.D., Amanatides, P.G., Scherer, S.E., Li, P.W, Hoskins, R.A., Galle, R.F. et al. (2000) The genome sequence of Drosophila melanogaster. Science, 287, 2185-2195.
54. Martin-Morris, L.E. and White, K. (1990) The Drosophila transcript encoded by the β-amyloid protein precursor-like gene is restricted to the nervous system. Development, 110, 185-195.
55. Adachi, H., Kume, A., Li, M., Nakagomi, Y., Niwa, H., Do, J., Sang, C., Kobayashi, Y., Doyu, M. and Sobue, G. (2001) Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death. Hum. Mol. Genet., 10, 1039-1048.
56. Hirose, F., Yamaguchi, M. and Matsukage, A. (1999) Targeted expression of the DNA binding domain of DRE-binding factor, a Drosophila transcription factor, attenuates DNA replication of the salivary gland and eye imaginal disc. Mol. Cell Biol., 19, 6020-6028.
57. Hirose, F., Yamaguchi, M. and Matsukage, A. (1994) Repression of regulatory factor for Drosophila DNA replication-related gene promoters by ZERKNÜLLT homeodomain protein. J. Biol. Chem., 269, 2937-2942.
58. Dunah, A.W., Jeong, H., Griffin, A., Kim, Y.M., Standaert, D.G., Hersch, S.M., Mouradian, M.M., Young, A.B., Tanese, N. and Krainc, D. (2002) Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science, 296, 2238-2243.
59. Li, S.H., Cheng, A.L., Zhou, H., Lam, S., Rao, M., Li, H. and Li, X.J. (2002) Interaction of Huntington disease protein with transcriptional activator Sp1. Mol. Cell Biol., 22, 1277-1287.
60. Perez, M.K., Paulson, H.L., Pendse, S.J., Saionz, S.J., Bonini, N.M. and Pittman, R.N. (1998) Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J. Cell. Biol., 143, 1457-1470.
61. Huang, C.C., Faber, P.W., Persichetti, F., Mittal, V., Vonsattel, J.P., MacDonald, M.E. and Gusella, J.F. (1998) Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins. Somat. Cell. Mol. Genet., 24, 217-233.
62. La Spada, A.R., Fu, Y.H., Sopher, B.L., Libby, R.T., Wang, X., Li, L.Y., Einum, D.D., Huang, J., Possin, D.E., Smith, A.C. et al. (2001) Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron, 31, 913-927.
63. Yu, Z.X., Li, S.H., Nguyen, H.P. and Li, X.J. (2002) Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice. Hum. Mol. Genet., 11, 905-914.
64. Nagai, Y., Tucker, T., Ren, H., Kenan, D.J., Henderson, B.S., Keene, J.D., Strittmatter, WJ. and Burke, J.R. (2000) Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening. J Biol. Chem., 275, 10437-10442.
65. Kazantsev, A., Walker, H.A., Slepko, N., Bear, J.E., Preisinger, E., Steffan, J.S., Zhu, Y.Z., Gertler, F.B., Housman, D.E., Marsh, J.L. et al. (2002) A bivalent huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila. Nat. Genet., 30, 367-376.
66. Williams, J.H., Daly, L.N., Ingley, E., Beaumont, J.G., Tilbrook, P.A., Lalonde, J.P., Stillitano, J.P. and Klinken, S.P. (1999) HLS7, a hemopoietic lineage switch gene homologous to the leukemia-inducing gene MLF1. EMBO J, 18, 5559-5566.
67. Panagopoulos, I., Fioretos, T., Isaksson, M., Samuelsson, U., Billstrom, R., Strombeck, B., Mitelman, F. and Johansson, B. (2001) Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). Hum. Mol. Genet., 10, 395-404.
68. Rowley, J.D., Reshmi, S., Sobulo, O., Musvee, T., Anastasi, J., Raimondi, S., Schneider, N.R., Barredo, J.C., Cantu, E.S., Schlegelberger, B. et al. (1997) All patients with the t(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood, 90, 535-541.
69. Sobulo, O.M., Borrow, J., Tomek, R., Reshmi, S., Harden, A., Schlegelberger, B., Housman, D., Doggett, N.A., Rowley, J.D. and Zeleznik-Le, N.J. (1997) MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc. Natl Acad Sci. USA, 94, 8732-8737.
70. Panagopoulos, I., Isaksson, M., Lindvall, C., Bjorkholm, M., Ahlgren, T., Fioretos, T, Heim, S., Mitelman, F. and Johansson, B. (2000) RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13). Genes Chromosomes Cancer, 28, 415-424.
71. Pao, G.M., Janknecht, R., Ruffner, H., Hunter, T. and Verma, I.M. (2000) CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc. Natl Acad Sci. USA, 97, 1020-1025.
72. Preudhomme, C. and Fenaux, P. (1997) The clinical significance of mutations of the p53 tumour suppressor gene in haematological malignancies. Br. J Haematol., 98, 502-511.
73. Ross, T.S., Bernard, O.A., Berger, R. and Gilliland, D.G. (1998) Fusion of humingtin Interacting protein 1 to platelet-derived growth factor β receptor (PDGF β R) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). Blood, 91, 4419-4426.
74. Sørensen, S.A., Fenger, K. and Olsen, J.H. (1999) Significantly lower incidence of cancer among patients with Huntington disease - An apoptotic effect of an expanded polyglutamine tract? Cancer, 86, 1342-1346.
75. Spradling, A.C. and Rubin, G.M. (1982) Transposition of cloned P-elements into Drosophila germ line chromosomes. Science, 218, 341-347.